Selected research
Market Structure
Global Marine Biopharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Marine Biopharmaceutical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Marine Biopharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Marine Biopharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Marine Biopharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Marine Biopharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Marine Biopharmaceutical include Takeda, Pfizer, GSK, TerSera Therapeutics, Seattle Genetics, Pharma Mar SA, Pelagia (EPAX), Nordic Naturals and GNC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Marine Biopharmaceutical market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Marine Biopharmaceutical and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Marine Biopharmaceutical revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Marine Biopharmaceutical market size, projected growth trends, production technologies, key applications, and end-use industries.
Marine Biopharmaceutical Segment by Company
Takeda
Pfizer
GSK
TerSera Therapeutics
Seattle Genetics
Pharma Mar SA
Pelagia (EPAX)
Nordic Naturals
GNC
Eisai Co
DSM
Croda
Carlson Labs
BASF
Amway
Marine Biopharmaceutical Segment by Type
Drugs
Health Supplement
Marine Biopharmaceutical Segment by Application
Hospital & Clinic
Pharmacy
Other
Marine Biopharmaceutical Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marine Biopharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Marine Biopharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marine Biopharmaceutical.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Marine Biopharmaceutical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Marine Biopharmaceutical industry.
Chapter 3: Detailed analysis of Marine Biopharmaceutical companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Marine Biopharmaceuticalrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drugs
- Health Supplement
Applications
- Hospital & Clinic
- Pharmacy
- Other
Companies covered
- Takeda
- Pfizer
- GSK
- TerSera Therapeutics
- Seattle Genetics
- Pharma Mar SA
- Pelagia (EPAX)
- Nordic Naturals
- GNC
- Eisai Co
- DSM
- Croda
- Carlson Labs
- BASF
- Amway
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Marine Biopharmaceutical Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Drugs
- 1.2.3 Health Supplement
- 1.3 Market Analysis by Application
- 1.3.1 Global Marine Biopharmaceutical Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital & Clinic
- 1.3.3 Pharmacy
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Marine Biopharmaceutical Growth Trends by Region
- 1.5.1 Global Marine Biopharmaceutical Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Marine Biopharmaceutical Market Size by Region (2021-2026)
- 1.5.3 Marine Biopharmaceutical Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Marine Biopharmaceutical Market Dynamics
- 2.1 Marine Biopharmaceutical Industry Trends
- 2.2 Marine Biopharmaceutical Industry Drivers
- 2.3 Marine Biopharmaceutical Industry Opportunities and Challenges
- 2.4 Marine Biopharmaceutical Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Marine Biopharmaceutical Revenue by Company (2021-2026)
- 3.2 Global Marine Biopharmaceutical Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Marine Biopharmaceutical Key Company Head office and Area Served
- 3.4 Global Marine Biopharmaceutical Company, Product Type & Application
- 3.5 Global Marine Biopharmaceutical Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Marine Biopharmaceutical Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Marine Biopharmaceutical Players Market Share by Revenue in 2025
- 3.6.3 2025 Marine Biopharmaceutical Tier 1, Tier 2, and Tier 3
4 Marine Biopharmaceutical Market by Type
- 4.1 Global Marine Biopharmaceutical Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Marine Biopharmaceutical Market Size by Type (2021-2032)
- 4.3 Global Marine Biopharmaceutical Market Size Share by Type (2021-2032)
5 Marine Biopharmaceutical Market by Application
- 5.1 Global Marine Biopharmaceutical Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Marine Biopharmaceutical Market Size by Application (2021-2032)
- 5.3 Global Marine Biopharmaceutical Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Takeda
- 6.1.1 Takeda Company Information
- 6.1.2 Takeda Business Overview
- 6.1.3 Takeda Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Takeda Marine Biopharmaceutical Product Portfolio
- 6.1.5 Takeda Recent Developments
- 6.2 Pfizer
- 6.2.1 Pfizer Company Information
- 6.2.2 Pfizer Business Overview
- 6.2.3 Pfizer Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Pfizer Marine Biopharmaceutical Product Portfolio
- 6.2.5 Pfizer Recent Developments
- 6.3 GSK
- 6.3.1 GSK Company Information
- 6.3.2 GSK Business Overview
- 6.3.3 GSK Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 GSK Marine Biopharmaceutical Product Portfolio
- 6.3.5 GSK Recent Developments
- 6.4 TerSera Therapeutics
- 6.4.1 TerSera Therapeutics Company Information
- 6.4.2 TerSera Therapeutics Business Overview
- 6.4.3 TerSera Therapeutics Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 TerSera Therapeutics Marine Biopharmaceutical Product Portfolio
- 6.4.5 TerSera Therapeutics Recent Developments
- 6.5 Seattle Genetics
- 6.5.1 Seattle Genetics Company Information
- 6.5.2 Seattle Genetics Business Overview
- 6.5.3 Seattle Genetics Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Seattle Genetics Marine Biopharmaceutical Product Portfolio
- 6.5.5 Seattle Genetics Recent Developments
- 6.6 Pharma Mar SA
- 6.6.1 Pharma Mar SA Company Information
- 6.6.2 Pharma Mar SA Business Overview
- 6.6.3 Pharma Mar SA Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Pharma Mar SA Marine Biopharmaceutical Product Portfolio
- 6.6.5 Pharma Mar SA Recent Developments
- 6.7 Pelagia (EPAX)
- 6.7.1 Pelagia (EPAX) Company Information
- 6.7.2 Pelagia (EPAX) Business Overview
- 6.7.3 Pelagia (EPAX) Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Pelagia (EPAX) Marine Biopharmaceutical Product Portfolio
- 6.7.5 Pelagia (EPAX) Recent Developments
- 6.8 Nordic Naturals
- 6.8.1 Nordic Naturals Company Information
- 6.8.2 Nordic Naturals Business Overview
- 6.8.3 Nordic Naturals Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Nordic Naturals Marine Biopharmaceutical Product Portfolio
- 6.8.5 Nordic Naturals Recent Developments
- 6.9 GNC
- 6.9.1 GNC Company Information
- 6.9.2 GNC Business Overview
- 6.9.3 GNC Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 GNC Marine Biopharmaceutical Product Portfolio
- 6.9.5 GNC Recent Developments
- 6.10 Eisai Co
- 6.10.1 Eisai Co Company Information
- 6.10.2 Eisai Co Business Overview
- 6.10.3 Eisai Co Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Eisai Co Marine Biopharmaceutical Product Portfolio
- 6.10.5 Eisai Co Recent Developments
- 6.11 DSM
- 6.11.1 DSM Company Information
- 6.11.2 DSM Business Overview
- 6.11.3 DSM Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 DSM Marine Biopharmaceutical Product Portfolio
- 6.11.5 DSM Recent Developments
- 6.12 Croda
- 6.12.1 Croda Company Information
- 6.12.2 Croda Business Overview
- 6.12.3 Croda Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Croda Marine Biopharmaceutical Product Portfolio
- 6.12.5 Croda Recent Developments
- 6.13 Carlson Labs
- 6.13.1 Carlson Labs Company Information
- 6.13.2 Carlson Labs Business Overview
- 6.13.3 Carlson Labs Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Carlson Labs Marine Biopharmaceutical Product Portfolio
- 6.13.5 Carlson Labs Recent Developments
- 6.14 BASF
- 6.14.1 BASF Company Information
- 6.14.2 BASF Business Overview
- 6.14.3 BASF Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 BASF Marine Biopharmaceutical Product Portfolio
- 6.14.5 BASF Recent Developments
- 6.15 Amway
- 6.15.1 Amway Company Information
- 6.15.2 Amway Business Overview
- 6.15.3 Amway Marine Biopharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Amway Marine Biopharmaceutical Product Portfolio
- 6.15.5 Amway Recent Developments
7 North America
- 7.1 North America Marine Biopharmaceutical Market Size (2021-2032)
- 7.2 North America Marine Biopharmaceutical Market Size by Type
- 7.2.1 North America Marine Biopharmaceutical Market Size by Type (2021-2026)
- 7.2.2 North America Marine Biopharmaceutical Market Size by Type (2027-2032)
- 7.2.3 North America Marine Biopharmaceutical Market Share by Type (2021-2032)
- 7.3 North America Marine Biopharmaceutical Market Size by Application
- 7.3.1 North America Marine Biopharmaceutical Market Size by Application (2021-2026)
- 7.3.2 North America Marine Biopharmaceutical Market Size by Application (2027-2032)
- 7.3.3 North America Marine Biopharmaceutical Market Share by Application (2021-2032)
- 7.4 North America Marine Biopharmaceutical Market Size by Country
- 7.4.1 North America Marine Biopharmaceutical Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Marine Biopharmaceutical Market Size by Country (2021-2026)
- 7.4.3 North America Marine Biopharmaceutical Market Size by Country (2027-2032)
- 7.4.4 North America Marine Biopharmaceutical Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Marine Biopharmaceutical Market Size (2021-2032)
- 8.2 Europe Marine Biopharmaceutical Market Size by Type
- 8.2.1 Europe Marine Biopharmaceutical Market Size by Type (2021-2026)
- 8.2.2 Europe Marine Biopharmaceutical Market Size by Type (2027-2032)
- 8.2.3 Europe Marine Biopharmaceutical Market Share by Type (2021-2032)
- 8.3 Europe Marine Biopharmaceutical Market Size by Application
- 8.3.1 Europe Marine Biopharmaceutical Market Size by Application (2021-2026)
- 8.3.2 Europe Marine Biopharmaceutical Market Size by Application (2027-2032)
- 8.3.3 Europe Marine Biopharmaceutical Market Share by Application (2021-2032)
- 8.4 Europe Marine Biopharmaceutical Market Size by Country
- 8.4.1 Europe Marine Biopharmaceutical Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Marine Biopharmaceutical Market Size by Country (2021-2026)
- 8.4.3 Europe Marine Biopharmaceutical Market Size by Country (2027-2032)
- 8.4.4 Europe Marine Biopharmaceutical Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Marine Biopharmaceutical Market Size (2021-2032)
- 9.2 China Marine Biopharmaceutical Market Size by Type
- 9.2.1 China Marine Biopharmaceutical Market Size by Type (2021-2026)
- 9.2.2 China Marine Biopharmaceutical Market Size by Type (2027-2032)
- 9.2.3 China Marine Biopharmaceutical Market Share by Type (2021-2032)
- 9.3 China Marine Biopharmaceutical Market Size by Application
- 9.3.1 China Marine Biopharmaceutical Market Size by Application (2021-2026)
- 9.3.2 China Marine Biopharmaceutical Market Size by Application (2027-2032)
- 9.3.3 China Marine Biopharmaceutical Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Marine Biopharmaceutical Market Size (2021-2032)
- 10.2 Asia Marine Biopharmaceutical Market Size by Type
- 10.2.1 Asia Marine Biopharmaceutical Market Size by Type (2021-2026)
- 10.2.2 Asia Marine Biopharmaceutical Market Size by Type (2027-2032)
- 10.2.3 Asia Marine Biopharmaceutical Market Share by Type (2021-2032)
- 10.3 Asia Marine Biopharmaceutical Market Size by Application
- 10.3.1 Asia Marine Biopharmaceutical Market Size by Application (2021-2026)
- 10.3.2 Asia Marine Biopharmaceutical Market Size by Application (2027-2032)
- 10.3.3 Asia Marine Biopharmaceutical Market Share by Application (2021-2032)
- 10.4 Asia Marine Biopharmaceutical Market Size by Country
- 10.4.1 Asia Marine Biopharmaceutical Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Marine Biopharmaceutical Market Size by Country (2021-2026)
- 10.4.3 Asia Marine Biopharmaceutical Market Size by Country (2027-2032)
- 10.4.4 Asia Marine Biopharmaceutical Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Marine Biopharmaceutical Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Marine Biopharmaceutical Market Size by Type
- 11.2.1 South America, Middle East & Africa Marine Biopharmaceutical Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Marine Biopharmaceutical Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Marine Biopharmaceutical Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Marine Biopharmaceutical Market Size by Application
- 11.3.1 South America, Middle East & Africa Marine Biopharmaceutical Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Marine Biopharmaceutical Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Marine Biopharmaceutical Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Marine Biopharmaceutical Market Size by Country
- 11.4.1 South America, Middle East & Africa Marine Biopharmaceutical Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Marine Biopharmaceutical Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Marine Biopharmaceutical Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Marine Biopharmaceutical Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst